,18 A study conducted by Carolina et al revealed that during the early phases of breast cancer progression, the suppression of NR2F1 by human epidermal growth factor receptor 2 (HER2) aids in the spread of cancer cells by initiating EMT and activating a combination of luminal and basal-like characteristics.19 The gene discussed is ERBB2; the disease is breast carcinoma.